Astrana Health, Inc. (NASDAQ:ASTH) Given Consensus Recommendation of “Moderate Buy” by Analysts

Astrana Health, Inc. (NASDAQ:ASTH) has received an average recommendation of “Moderate Buy” from the nine ratings firms that are presently covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $43.1429.

A number of analysts have issued reports on ASTH shares. Robert W. Baird set a $45.00 price objective on Astrana Health in a research note on Friday, May 8th. Barclays lifted their price objective on Astrana Health from $26.00 to $37.00 and gave the stock an “equal weight” rating in a research note on Monday. Weiss Ratings raised Astrana Health from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Needham & Company LLC boosted their target price on Astrana Health from $30.00 to $41.00 and gave the company a “buy” rating in a research report on Friday, May 8th. Finally, TD Cowen boosted their target price on Astrana Health from $35.00 to $45.00 and gave the company a “buy” rating in a research report on Tuesday.

Astrana Health Stock Performance

NASDAQ:ASTH opened at $38.26 on Monday. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.35 and a quick ratio of 1.40. Astrana Health has a 1 year low of $18.08 and a 1 year high of $39.93. The stock’s 50 day simple moving average is $29.30 and its two-hundred day simple moving average is $25.96. The company has a market cap of $2.13 billion, a price-to-earnings ratio of 62.72 and a beta of 0.98.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.45. Astrana Health had a return on equity of 9.22% and a net margin of 0.86%.The business had revenue of $965.10 million for the quarter, compared to the consensus estimate of $949.21 million. During the same quarter in the previous year, the company posted $0.42 EPS. The company’s revenue was up 55.6% compared to the same quarter last year. As a group, equities analysts anticipate that Astrana Health will post 1.25 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Astrana Health

Large investors have recently modified their holdings of the stock. Signaturefd LLC increased its position in shares of Astrana Health by 57.9% during the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after purchasing an additional 388 shares during the last quarter. GAMMA Investing LLC increased its position in shares of Astrana Health by 144.7% during the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock valued at $37,000 after purchasing an additional 871 shares during the last quarter. Strs Ohio bought a new position in shares of Astrana Health during the 4th quarter valued at approximately $40,000. Covestor Ltd increased its position in shares of Astrana Health by 210.6% during the 3rd quarter. Covestor Ltd now owns 3,233 shares of the company’s stock valued at $92,000 after purchasing an additional 2,192 shares during the last quarter. Finally, Tower Research Capital LLC TRC increased its position in shares of Astrana Health by 323.3% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after purchasing an additional 3,517 shares during the last quarter. Institutional investors own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.